- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/04 - Chelating agents
Patent holdings for IPC class A61P 39/04
Total number of patents in this class: 195
10-year publication summary
|
7
|
10
|
8
|
5
|
8
|
11
|
11
|
14
|
11
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10801 |
9 |
| The Regents of the University of California | 20355 |
8 |
| Uop LLC | 4273 |
7 |
| Universite Claude Bernard Lyon 1 | 1057 |
6 |
| Mexbrain | 30 |
6 |
| Chelation Partners Incorporated | 8 |
4 |
| Institut Gustave Roussy | 271 |
4 |
| Universite de Bretagne Occidentale | 108 |
4 |
| AustinPx, LLC | 26 |
4 |
| Cornell University | 3377 |
3 |
| University of Kansas | 894 |
3 |
| The University of Sydney | 620 |
3 |
| Worcester Polytechnic Institute | 527 |
3 |
| Fe Pharmaceuticals (Canada) Inc. | 5 |
3 |
| Novartis AG | 10494 |
2 |
| Murata Manufacturing Co., Ltd. | 25214 |
2 |
| The Board of Trustees of the University of Illinois | 2731 |
2 |
| University of Florida Research Foundation, Inc. | 4110 |
2 |
| Apotex Technologies Inc. | 16 |
2 |
| Assistance Publique - Hopitaux de Paris | 1033 |
2 |
| Other owners | 116 |